Characteristics of outcomes Number of patients/ Total patients number (%) 6 months after transplantation 12 months after transplantation Follow-up > 12 months after transplantation (mean 26 months) Improvement 30/55 (55%) 30/44 (68%) 30/44 (68%) Stabilization 25/55 (45%) 14/44 (32%) 14/44 (32%) Progression 0/55 (0%) 0/44 (0%) 0/44 (0%)

Table 2: Efficacy of NM-AHSCT with Mitoxantrone consolidation therapy in MS patients.